Analysis of BRAF V600E mutation in bilateral well-differentiated thyroid carcinoma
10.13315/j.cnki.cjcep.2016.12.012
- VernacularTitle:分化型甲状腺癌中BRAF V600E突变分析
- Author:
Yan LUO
;
Ning AN
;
Lan WANG
;
Yun LU
;
Fang LIU
- Keywords:
thyroid neoplasms;
bilateral well-differentiated thyroid carcinoma;
papillary thyoid carcinoma;
BRAF V600E mutation;
histological variant
- From:
Chinese Journal of Clinical and Experimental Pathology
2016;32(12):1368-1370
- CountryChina
- Language:Chinese
-
Abstract:
Purpose To investigate the correlation between BRAF V600E mutation and clinicopathologic parameters in bilateral welldifferentiated thyroid carcinoma.Method Collected 80 patients with papillary thyoid carcinoma (PTC) (67 patients with classical type,8 patients with follicular variant,3 patients with oncocytic variant,2 patients with tall cell variant),5 patients with follicular carcinoma and 30 normal tissues near the tumor,BRAF V600E mutation was detected via polymerase chain reaction.Result The presence of BRAF V600E mutation was found in 52 patients with PTC (65.0％),the mutation was not in the 5 patients with ollicular carcinoma as well as in the 30 normal tissues near the tumor.The BRAF V600E mutation was positively correlated with age,capsule invasion,lymph node metastasis,tumor clinical stage.In the histological variant of PTC,the BRAF V600E mutation rate of classical type and tall cell variant is very high (70.1％,100.0％),but the BRAF V600E mutation rate of follicular variant is very low (33.3％).Conclusion The BRAF V600E mutation rates are different in different age groups.The BRAF V600E mutation was positively correlated with capsule invasion,lymph node metastasis,tumor clinical stage.The BRAF V600E mutation rate of classical type and tall cell variant is very higher than follicular variant.
